Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Jin Yang Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Jin Yang Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Jinling Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Jinling Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Jiuzhitang Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Jiuzhitang Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Jiwa Bio-Pharm Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Jiwa Bio-Pharm Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Johnson & Johnson Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Johnson & Johnson Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Johnson Chemical Pharmaceutical Works Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Johnson Chemical Pharmaceutical Works Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Joincare Pharmaceutical Group Industry Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Joincare Pharmaceutical Group Industry Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

JSC Grindeks Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

JSC Grindeks Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Jubilant Life Sciences Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Jubilant Life Sciences Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Jupiter Bioscience Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Jupiter Bioscience Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kaken Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kaken Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kalahari Greentech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kalahari Greentech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kamada Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kamada Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kane Biotech Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kane Biotech Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kappac Pharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kappac Pharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Karo Bio AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Karo Bio AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

KDL Biotech Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

KDL Biotech Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kendle International Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kendle International Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kent International Holdings Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kent International Holdings Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kerala Ayurveda Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kerala Ayurveda Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Keryx Biopharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Keryx Biopharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kilitch Drugs (India) Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kilitch Drugs (India) Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kimia Farama Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kimia Farama Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

King Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

King Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kissei Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kissei Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kiwa Bio-Tech Products Group Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kiwa Bio-Tech Products Group Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kolon Life Science Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kolon Life Science Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Komipharm International Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Komipharm International Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kopran Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kopran Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Korea United Pharm Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Korea United Pharm Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Korean Drug Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Korean Drug Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kotra Industries Bhd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kotra Industries Bhd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kpx Life Science Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kpx Life Science Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Krebs Biochemicals & Industries Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Krebs Biochemicals & Industries Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kukje Pharmaceutical Industrial Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kukje Pharmaceutical Industrial Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kun Run Biotechnology, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kun Run Biotechnology, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kunming Pharmaceutical Corp Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kunming Pharmaceutical Corp Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alvogen Korea Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alvogen Korea Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 99 pages

KV Pharmaceutical Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

KV Pharmaceutical Co. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kwang Dong Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kwang Dong Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

KYORIN Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

KYORIN Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kyowa Hakko Kirin Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kyowa Hakko Kirin Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kyto BioPharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kyto BioPharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kyung Dong Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kyung Dong Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 79 pages

Kyung Nam Pharm Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kyung Nam Pharm Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

La Jolla Pharmaceutical Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

La Jolla Pharmaceutical Co. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

LAB Research, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

LAB Research, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Labopharm Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Labopharm Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Laboratorios Almirall SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Laboratorios Almirall SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Laboratorios Andromaco S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Laboratorios Andromaco S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1